COO logo

COOPER COS INC/THE

COONASDAQ
πŸ† #743 by market capEarnings Dec 3US Equity
$59.53β–Ό $0.35 (βˆ’0.59%)
Market closed Β· at close
πŸ””
Track COO
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.6%
7dβ–Ό 3.4%
14dβ–² 3.7%
30dβ–² 5.1%
ytdβ–Ό 27.3%
1yβ–Ό 14.5%
🏦Market Cap
$11.32B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
4.7%
Slowing
πŸ“ŠGross Margin
65.9%
High
πŸ’΅FCF Margin
16.0%
Healthy
βš–οΈP/S Ratio
2.7x
Cheap
Otter Score
84
Strong

Trading Snapshot

Day Range
$58.85 – $60.29
52-Week Range
$51.01 – $89.83
Volume (shares)
260,169
Avg Volume (shares)
β€”
Shares Outstanding
190.2M
Next Earnings
2026-12-03

Fundamentals Snapshot

Annual Revenue
$4.09B
Last Q Revenue
$1.07B
P/E Ratio
20.1
P/S Ratio
2.7x
EPS (TTM)
$2.93
Dividend Yield
0.00%
Dilution (1yr)
βˆ’1.5%
COO logo

COOPER COS INC/THE

COO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$4.1Bβ–² +5.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
60.7%β–Ό βˆ’9.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$683Mβ–Ό βˆ’3.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$434Mβ–² +50.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
198.1Mβ–Ό βˆ’1.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2.7Bβ–Ό βˆ’$197M YoY
StockOtter Β· stockotter.space

About COOPER COS INC/THE

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
84/100

Analyst Ratings

β“˜
Consensus
Buy
22 analysts
Strong Buy3
Buy5
Hold14
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.